Cargando…

The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report

Leydig cell tumors (LCTs) refer to tumors of the stroma of the genital strand, which are found mainly in postmenopausal women. The diagnosis of LCTs in postmenopausal women is associated with specific difficulties and is based on the identification of hyperandrogenism with clinical manifestations of...

Descripción completa

Detalles Bibliográficos
Autores principales: Suturina, Larisa V., Sharifulin, Eldar M., Sharifulin, Maharam A., Lazareva, Ludmila M., Danusevich, Irina N., Ievleva, Kseniia D., Nadeliaeva, Iana G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320079/
https://www.ncbi.nlm.nih.gov/pubmed/35888744
http://dx.doi.org/10.3390/metabo12070620
_version_ 1784755705923764224
author Suturina, Larisa V.
Sharifulin, Eldar M.
Sharifulin, Maharam A.
Lazareva, Ludmila M.
Danusevich, Irina N.
Ievleva, Kseniia D.
Nadeliaeva, Iana G.
author_facet Suturina, Larisa V.
Sharifulin, Eldar M.
Sharifulin, Maharam A.
Lazareva, Ludmila M.
Danusevich, Irina N.
Ievleva, Kseniia D.
Nadeliaeva, Iana G.
author_sort Suturina, Larisa V.
collection PubMed
description Leydig cell tumors (LCTs) refer to tumors of the stroma of the genital strand, which are found mainly in postmenopausal women. The diagnosis of LCTs in postmenopausal women is associated with specific difficulties and is based on the identification of hyperandrogenism with clinical manifestations of virilization, which has an erased picture in postmenopausal women. LCTs require differential diagnosis with other causes of hyperandrogenism. We present the clinical case of a 55-year-old Russian postmenopausal patient with LCTs of the right ovary, significantly increased levels of androgens, and rapidly progressive clinical signs of hyperandrogenism. The patient underwent laparoscopic bilateral salpingo-oophorectomy, and the androgen indices reached average values by the first and third month after surgery. This case demonstrates that LCTs are often benign with a good prognosis and normalization of the clinical and laboratory manifestations of hyperandrogenism after surgical treatment. The type of surgery performed (bilateral salpingo-oophorectomy rather than unilateral) is recommended as the treatment of choice for LCTs in postmenopausal patients.
format Online
Article
Text
id pubmed-9320079
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93200792022-07-27 The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report Suturina, Larisa V. Sharifulin, Eldar M. Sharifulin, Maharam A. Lazareva, Ludmila M. Danusevich, Irina N. Ievleva, Kseniia D. Nadeliaeva, Iana G. Metabolites Case Report Leydig cell tumors (LCTs) refer to tumors of the stroma of the genital strand, which are found mainly in postmenopausal women. The diagnosis of LCTs in postmenopausal women is associated with specific difficulties and is based on the identification of hyperandrogenism with clinical manifestations of virilization, which has an erased picture in postmenopausal women. LCTs require differential diagnosis with other causes of hyperandrogenism. We present the clinical case of a 55-year-old Russian postmenopausal patient with LCTs of the right ovary, significantly increased levels of androgens, and rapidly progressive clinical signs of hyperandrogenism. The patient underwent laparoscopic bilateral salpingo-oophorectomy, and the androgen indices reached average values by the first and third month after surgery. This case demonstrates that LCTs are often benign with a good prognosis and normalization of the clinical and laboratory manifestations of hyperandrogenism after surgical treatment. The type of surgery performed (bilateral salpingo-oophorectomy rather than unilateral) is recommended as the treatment of choice for LCTs in postmenopausal patients. MDPI 2022-07-04 /pmc/articles/PMC9320079/ /pubmed/35888744 http://dx.doi.org/10.3390/metabo12070620 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Suturina, Larisa V.
Sharifulin, Eldar M.
Sharifulin, Maharam A.
Lazareva, Ludmila M.
Danusevich, Irina N.
Ievleva, Kseniia D.
Nadeliaeva, Iana G.
The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report
title The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report
title_full The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report
title_fullStr The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report
title_full_unstemmed The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report
title_short The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report
title_sort leydig steroid cell tumor in a postmenopausal woman with clinical and biochemical hyperandrogenism: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9320079/
https://www.ncbi.nlm.nih.gov/pubmed/35888744
http://dx.doi.org/10.3390/metabo12070620
work_keys_str_mv AT suturinalarisav theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT sharifulineldarm theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT sharifulinmaharama theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT lazarevaludmilam theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT danusevichirinan theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT ievlevakseniiad theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT nadeliaevaianag theleydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT suturinalarisav leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT sharifulineldarm leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT sharifulinmaharama leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT lazarevaludmilam leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT danusevichirinan leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT ievlevakseniiad leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport
AT nadeliaevaianag leydigsteroidcelltumorinapostmenopausalwomanwithclinicalandbiochemicalhyperandrogenismacasereport